Stefan Borgwardt
Research group “Translational Psychiatry“
Director, Department of Psychiatry and Psychotherapy, Department of Psychosomatics and Psychotherapy, Centre of Integrative Psychiatry, Schleswig-Holstein University Hospital, Campus Lübeck (Germany)
Chair of Psychiatry and Psychotherapy, University of Lübeck (Germany)
Visiting Professor, Institute of Psychiatry, King’s College London (UK)
Professor of Neuropsychiatry, University of Basel (CH)
- Prof Dr Christina Andreou (psychiatrist)
- Dr Mihai Avram (psychologist)
- Dr Frederike Buschmann (physician)
- Dr Léon Franzen (neuroscientist)
- Dr Alexandra Korda (biomedical engineer)
- Dr Helena Rogg (physician)
- Sofia Eickhoff (psychologist & PhD candidate)
- Marco Heide (psychiatrist)
- Frederike Schröpfer (occupational therapist)
- Kris Sievert (physician)
2011 – 2021 Professor of Neuropsychiatry, University of Basel (Switzerland)
2011 – 2019 Chief Physician, Deputy Clinical Director Adult Psychiatry, Department of Psychiatry (UPK), University of Basel (Switzerland)
2008 – 2010 Senior Physician, Psychiatric Outpatient Department and Neuroradiological Department MIAC, University Hospital Basel (Switzerland)
2007 – 2007 Senior House Officer, REHAB Basel (Switzerland)
2004 – 2006 Senior House Officer and Research Fellow, Institute of Psychiatry, King’s College London (UK)
2002 – 2004 and 2006 Senior House Officer, Psychiatric Outpatient Department, University Hospital Basel (Switzerland)
1995 – 2002 Medical Degree, Charité, Humboldt-University of Berlin (Germany)
2002 Approbation, Charité, Humboldt-University of Berlin (Germany)
2004 Dissertation, Charité, Humboldt-University of Berlin (Germany)
2008 Qualifications in University Didactics, University of Basel (Switzerland)
2008 Full qualification as Specialist in Psychiatry and Psychotherapy, Psychiatric University Hospital Basel (Switzerland)
2009 Habilitation, Medical Faculty, University of Basel (Switzerland)
2009 Qualification as Psychotherapist of Cognitive-Behavioral Therapy, University Hospital Basel (Switzerland)
2010 Venia legendi in Neuropsychiatry
2013 Specialisation in Consultation and Liaison Psychiatry, University Hospital Basel (Switzerland)
2017 Master of Business Administration (MBA) in Academic Management, University of Basel (Switzerland)
Stefan Borgwardt’s research focus includes structural and functional neuroimaging, pharmacology neuroimaging methods, the prodromal and early phase of psychosis, neurocognitive and genetic mechanisms in schizophrenia, and neurofunctional mechanisms of cannabinoids and heroin. Clinical interests include prodromal and early psychosis and neuropsychiatry.
- Andreou C, Borgwardt S. Structural and functional imaging markers for susceptibility to psychosis. Mol Psychiatry. 2020 Nov;25(11):2773-2785. IF 12.4
- Fusar-Poli P, […], Borgwardt S, Lawrie S, Parnas J, McGuire P.Transdiagnostic Psychiatry: A systematic review. World Psychiatry 2019, 18:192-207. IF 30
- Diaconescu AO, Hauke DJ, Borgwardt S. Models of persecutory delusions: A mechanistic insight into the early stages of psychosis. Molecular Psychiatry 2019;24(9):1258-1267. IF 11.6
- Koutsouleris N, […] Borgwardt S, and the PRONIA Consortium. Prediction Models of Functional Outcomes for Individuals With Recent-Onset Depression or in the Clinical High-Risk State for Psychosis: A Multimodal, Multisite Machine Learning Analysis. JAMA Psychiatry, 2018;75(11):1156-1172. IF 16.6
- Schmidt A, Walter M, Gerber H, Seifritz E, Brenneisen R, Wiesbeck GA, Riecher-Rössler A, Lang UE, Borgwardt S (2015) Normalizing effect of heroin maintenance treatment on stress-induced brain connectivity. Brain, 138(Pt 1):217-28. IF 10.2
Research Awards (selection):
Inclusion in Clarivate Analytics’s list of Highly Cited Researchers 2018/2019/2020/2021/2022
Lundbeck Institute Psychiatry Prize (2012: CHF 10.000)
Biogen-Dompe Research Prize (2011: CHF 40.000)
Gerd-Huber Prize for psychosis prevention (2010: EUR 10.000)
SSBP Young Investigator Award (2007: CHF 5000)
Grants and Fellowships as PI (selection):
Swiss National Science Foundation (SNF) Grant “Sinergia”, (2019-2022: CHF 2.602.315 total;
CHF 549.800 own sum)
Gertrud Thalmann-Fonds “LAD” study (2019-2022: CHF 669.700)
ERANET Grant SYNSCHIZ (2017-2020: CHF 279.447 )
EU FP7 Grant – PRONIA (2013-2019: EUR 6.000.000 total; EUR 893.000 own sum)
Editorial Boards:
Frontiers in Psychiatry (Chief Editor)
Schizophrenia Bulletin
Journal of Affective Disorders
Journal of Psychiatry Neuroscience (JPN)
Swiss Medical Weekly